Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease

Introduction: Data on longitudinal trajectory of kidney function decline and fluctuation in albuminuria leading to end-stage kidney disease (ESKD) is sparse in patients with type 2 diabetes. Methods: Using data from an observational study of patients with type 2 diabetes and biopsy-confirmed diabeti...

Full description

Bibliographic Details
Published in:Kidney International Reports
Main Authors: Masayuki Yamanouchi, Naoki Sawa, Tadashi Toyama, Miho Shimizu, Megumi Oshima, Yusuke Yoshimura, Hisashi Sugimoto, Shigekazu Kurihara, Yuki Oba, Daisuke Ikuma, Hiroki Mizuno, Akinari Sekine, Tatsuya Suwabe, Junichi Hoshino, Yoshifumi Ubara, Shigeko Hara, Kengo Furuichi, Takashi Wada
Format: Article
Language:English
Published: Elsevier 2024-02-01
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024923015802
_version_ 1849569434558005248
author Masayuki Yamanouchi
Naoki Sawa
Tadashi Toyama
Miho Shimizu
Megumi Oshima
Yusuke Yoshimura
Hisashi Sugimoto
Shigekazu Kurihara
Yuki Oba
Daisuke Ikuma
Hiroki Mizuno
Akinari Sekine
Tatsuya Suwabe
Junichi Hoshino
Yoshifumi Ubara
Shigeko Hara
Kengo Furuichi
Takashi Wada
author_facet Masayuki Yamanouchi
Naoki Sawa
Tadashi Toyama
Miho Shimizu
Megumi Oshima
Yusuke Yoshimura
Hisashi Sugimoto
Shigekazu Kurihara
Yuki Oba
Daisuke Ikuma
Hiroki Mizuno
Akinari Sekine
Tatsuya Suwabe
Junichi Hoshino
Yoshifumi Ubara
Shigeko Hara
Kengo Furuichi
Takashi Wada
author_sort Masayuki Yamanouchi
collection DOAJ
container_title Kidney International Reports
description Introduction: Data on longitudinal trajectory of kidney function decline and fluctuation in albuminuria leading to end-stage kidney disease (ESKD) is sparse in patients with type 2 diabetes. Methods: Using data from an observational study of patients with type 2 diabetes and biopsy-confirmed diabetic kidney disease (DKD), generalized additive mixed models (GAMMs) were performed to quantify patterns of longitudinal trajectory of estimated glomerular filtration rate (eGFR) decline to ESKD associated with repeated measures of urine albumin-to-creatinine ratio (ACR). Results: Over a median follow-up period of 3.3 years, 155 of 319 patients progressed to ESKD. Among these patients, 91.6% exhibited a curvilinear pattern in their eGFR trajectory. The median coefficient of variation for ACR, representing the variability in ACR measurements, was 48.9 (interquartile range: 36.9, 68.2). The median compound annual growth rate (CAGR) for ACR, reflecting the variation in ACR progression over time, was 43.6% (interquartile range: 0.0, 102.5); and 84.5% of patients developed nephrotic-range albuminuria, with a majority remaining nephrotic and subsequently progressing to ESKD. There was a positive association between the instantaneous speed of eGFR decline and ACR. Conclusion: The observed curvilinear pattern in eGFR trajectory, high variability in ACR progression over time, and positive correlation between the speed of eGFR decline and ACR highlight the complex dynamics of disease progression and emphasize close monitoring of ACR fluctuation over time in patients with DKD.
format Article
id doaj-art-7db4e2545cc3469bbfe8ada03fba7457
institution Directory of Open Access Journals
issn 2468-0249
language English
publishDate 2024-02-01
publisher Elsevier
record_format Article
spelling doaj-art-7db4e2545cc3469bbfe8ada03fba74572025-08-20T02:31:47ZengElsevierKidney International Reports2468-02492024-02-019232333310.1016/j.ekir.2023.11.004Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney DiseaseMasayuki Yamanouchi0Naoki Sawa1Tadashi Toyama2Miho Shimizu3Megumi Oshima4Yusuke Yoshimura5Hisashi Sugimoto6Shigekazu Kurihara7Yuki Oba8Daisuke Ikuma9Hiroki Mizuno10Akinari Sekine11Tatsuya Suwabe12Junichi Hoshino13Yoshifumi Ubara14Shigeko Hara15Kengo Furuichi16Takashi Wada17Nephrology Center, Toranomon Hospital, Tokyo, Japan; Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan; Okinaka Memorial Institute for Medical Research, Tokyo, Japan; Department of Nephrology and Rheumatology, Kanazawa University, Ishikawa, Japan; Department of Nephrology, Kanazawa Medical University School of Medicine, Ishikawa, Japan; Correspondence: Masayuki Yamanouchi, Nephrology Center, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.Nephrology Center, Toranomon Hospital, Tokyo, Japan; Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanDepartment of Nephrology and Rheumatology, Kanazawa University, Ishikawa, JapanDepartment of Nephrology and Rheumatology, Kanazawa University, Ishikawa, JapanDepartment of Nephrology and Rheumatology, Kanazawa University, Ishikawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital, Tokyo, JapanNephrology Center, Toranomon Hospital, Tokyo, Japan; Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanDepartment of Medicine, Kidney Center, Tokyo Women’s Medical University, Tokyo, JapanNephrology Center, Toranomon Hospital, Tokyo, Japan; Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanHara Press Center Clinic, Tokyo, JapanDepartment of Nephrology, Kanazawa Medical University School of Medicine, Ishikawa, JapanDepartment of Nephrology and Rheumatology, Kanazawa University, Ishikawa, Japan; Takashi Wada, Kanazawa University, 13-1 Takaramachi, Kanazawa 920-0934, Japan.Introduction: Data on longitudinal trajectory of kidney function decline and fluctuation in albuminuria leading to end-stage kidney disease (ESKD) is sparse in patients with type 2 diabetes. Methods: Using data from an observational study of patients with type 2 diabetes and biopsy-confirmed diabetic kidney disease (DKD), generalized additive mixed models (GAMMs) were performed to quantify patterns of longitudinal trajectory of estimated glomerular filtration rate (eGFR) decline to ESKD associated with repeated measures of urine albumin-to-creatinine ratio (ACR). Results: Over a median follow-up period of 3.3 years, 155 of 319 patients progressed to ESKD. Among these patients, 91.6% exhibited a curvilinear pattern in their eGFR trajectory. The median coefficient of variation for ACR, representing the variability in ACR measurements, was 48.9 (interquartile range: 36.9, 68.2). The median compound annual growth rate (CAGR) for ACR, reflecting the variation in ACR progression over time, was 43.6% (interquartile range: 0.0, 102.5); and 84.5% of patients developed nephrotic-range albuminuria, with a majority remaining nephrotic and subsequently progressing to ESKD. There was a positive association between the instantaneous speed of eGFR decline and ACR. Conclusion: The observed curvilinear pattern in eGFR trajectory, high variability in ACR progression over time, and positive correlation between the speed of eGFR decline and ACR highlight the complex dynamics of disease progression and emphasize close monitoring of ACR fluctuation over time in patients with DKD.http://www.sciencedirect.com/science/article/pii/S2468024923015802diabetic kidney diseaseglomerular filtration ratealbuminuriaend-stage kidney diseasetrajectory of eGFRfluctuation in albuminuria
spellingShingle Masayuki Yamanouchi
Naoki Sawa
Tadashi Toyama
Miho Shimizu
Megumi Oshima
Yusuke Yoshimura
Hisashi Sugimoto
Shigekazu Kurihara
Yuki Oba
Daisuke Ikuma
Hiroki Mizuno
Akinari Sekine
Tatsuya Suwabe
Junichi Hoshino
Yoshifumi Ubara
Shigeko Hara
Kengo Furuichi
Takashi Wada
Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease
diabetic kidney disease
glomerular filtration rate
albuminuria
end-stage kidney disease
trajectory of eGFR
fluctuation in albuminuria
title Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease
title_full Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease
title_fullStr Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease
title_full_unstemmed Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease
title_short Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease
title_sort trajectory of gfr decline and fluctuation in albuminuria leading to end stage kidney disease in patients with biopsy confirmed diabetic kidney disease
topic diabetic kidney disease
glomerular filtration rate
albuminuria
end-stage kidney disease
trajectory of eGFR
fluctuation in albuminuria
url http://www.sciencedirect.com/science/article/pii/S2468024923015802
work_keys_str_mv AT masayukiyamanouchi trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT naokisawa trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT tadashitoyama trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT mihoshimizu trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT megumioshima trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT yusukeyoshimura trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT hisashisugimoto trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT shigekazukurihara trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT yukioba trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT daisukeikuma trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT hirokimizuno trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT akinarisekine trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT tatsuyasuwabe trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT junichihoshino trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT yoshifumiubara trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT shigekohara trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT kengofuruichi trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease
AT takashiwada trajectoryofgfrdeclineandfluctuationinalbuminurialeadingtoendstagekidneydiseaseinpatientswithbiopsyconfirmeddiabetickidneydisease